地高辛的代谢与吸收部位。
Metabolism of digoxin and absorption site.
作者信息
Magnusson J O, Bergdahl B, Bogentoft C, Jonsson U E
出版信息
Br J Clin Pharmacol. 1982 Aug;14(2):284-5. doi: 10.1111/j.1365-2125.1982.tb01976.x.
Abstract
After oral intake of enteric-coated granules containing [3H]-digoxin extensive metabolism was observed. Maximum 66% of the 24 h urinary excretion was identified as [3H]-dihydrodigoxin, using high performance liquid chromatography for the analysis. It is suggested that metabolism of digoxin may depend on the absorption site.
摘要
口服含[3H]-地高辛的肠溶颗粒后，观察到广泛的代谢。使用高效液相色谱法进行分析，发现24小时尿排泄量中最高有66%被鉴定为[3H]-二氢地高辛。提示地高辛的代谢可能取决于吸收部位。
相似文献
1
Metabolism of digoxin and absorption site.地高辛的代谢与吸收部位。
Br J Clin Pharmacol. 1982 Aug;14(2):284-5. doi: 10.1111/j.1365-2125.1982.tb01976.x.
2
Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin.摄入地高辛微囊制剂后二氢地高辛的代谢增加。
Eur J Clin Pharmacol. 1984;27(2):197-202. doi: 10.1007/BF00544045.
3
Absorption of digoxin from a new microencapsulated formulation.地高辛从一种新型微囊化制剂中的吸收情况。
Eur J Clin Pharmacol. 1980 Jun;17(6):443-7. doi: 10.1007/BF00570162.
4
Metabolism of digoxin after oral and intrajejunal administration.口服和空肠内给药后地高辛的代谢
Br J Clin Pharmacol. 1983 Dec;16(6):741-2. doi: 10.1111/j.1365-2125.1983.tb02255.x.
5
A completely absorbed oral preparation of digoxin.
Clin Pharmacol Ther. 1976 Jun;19(6):746-51. doi: 10.1002/cpt1976196746.
6
The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.通过特定的高效液相色谱法测定的三种口服制剂中地高辛的生物利用度。
Br J Clin Pharmacol. 1993 Feb;35(2):136-42. doi: 10.1111/j.1365-2125.1993.tb05679.x.
7
Influence of soft gelatin on digoxin absorption.软明胶对地高辛吸收的影响。
Br J Clin Pharmacol. 1978 May;5(5):461-3.
8
The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
Eur J Clin Pharmacol. 1978 Dec 18;14(5):357-60. doi: 10.1007/BF00611906.
9
Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.
Clin Pharmacol Ther. 1983 Dec;34(6):738-43. doi: 10.1038/clpt.1983.243.
10
Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability.
J Pharm Sci. 1977 Mar;66(3):314-25. doi: 10.1002/jps.2600660304.
引用本文的文献
1
The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine.肠道微生物群与口服药物之间的相互作用及其对推进精准医学的影响。
Metabolites. 2023 May 21;13(5):674. doi: 10.3390/metabo13050674.
2
Bioavailability Based on the Gut Microbiota: a New Perspective.基于肠道菌群的生物利用度：一个新视角。
Microbiol Mol Biol Rev. 2020 Apr 29;84(2). doi: 10.1128/MMBR.00072-19. Print 2020 May 20.
3
Xenobiotics shape the physiology and gene expression of the active human gut microbiome.外源性物质塑造了活跃的人类肠道微生物组的生理学和基因表达。
Cell. 2013 Jan 17;152(1-2):39-50. doi: 10.1016/j.cell.2012.10.052.
4
Metabolism of digoxin after oral and intrajejunal administration.口服和空肠内给药后地高辛的代谢
Br J Clin Pharmacol. 1983 Dec;16(6):741-2. doi: 10.1111/j.1365-2125.1983.tb02255.x.
5
Fasting and postprandial absorption of digoxin from a microencapsulated formulation.地高辛微囊制剂的空腹及餐后吸收情况
Eur J Clin Pharmacol. 1983;25(2):207-10. doi: 10.1007/BF00543792.
6
Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin.摄入地高辛微囊制剂后二氢地高辛的代谢增加。
Eur J Clin Pharmacol. 1984;27(2):197-202. doi: 10.1007/BF00544045.
7
Effect of guar gum, a fibre preparation, on digoxin and penicillin absorption in man.纤维制剂瓜尔胶对人体地高辛和青霉素吸收的影响。
Eur J Clin Pharmacol. 1984;26(2):279-81. doi: 10.1007/BF00630301.
本文引用的文献
1
Absorption of digoxin from a new microencapsulated formulation.地高辛从一种新型微囊化制剂中的吸收情况。
Eur J Clin Pharmacol. 1980 Jun;17(6):443-7. doi: 10.1007/BF00570162.
2
Inactivation of digoxin by the gut flora: reversal by antibiotic therapy.肠道菌群对洋地黄毒苷的灭活作用：抗生素治疗可使其逆转。
N Engl J Med. 1981 Oct 1;305(14):789-94. doi: 10.1056/NEJM198110013051403.
3
Determination of tritiated digoxin and metabolites in urine by liquid chromatography.用液相色谱法测定尿中氚标记地高辛及其代谢物
J Chromatogr. 1981 May 8;223(2):401-8. doi: 10.1016/s0378-4347(00)80113-9.
4
Urinary excretion of reduced metabolites of digoxin.地高辛还原代谢产物的尿排泄
Am J Med. 1981 Jul;71(1):67-74. doi: 10.1016/0002-9343(81)90260-6.
5
The absorption of orally administered (12 - 3 H)digoxin in man.
Clin Sci. 1972 Oct;43(4):507-18. doi: 10.1042/cs0430507.
6
Bioavailability of digoxin.
Lancet. 1972 Sep 30;2(7779):708. doi: 10.1016/s0140-6736(72)92112-5.
Zotero 插件